Objectives: The aim of this study was to evaluate the impact of olmesartan on progression of
coronary atherosclerosis. Background: Prior intravascular ultrasound (IVUS) trial results …

BACKGROUND: The previous OLIVUS trial reported a positive role in achieving a lower rate
of coronary atheroma progression through the administration of Olmesartan, an …

BACKGROUND: In patients with coronary artery disease (CAD), therapies designed to
prevent clinical events are not always associated with significant reduction in coronary …

ContextPrior intravascular ultrasound (IVUS) trials have demonstrated slowing or halting of
atherosclerosis progression with statin therapy but have not shown convincing evidence of …

Background Although statins have been shown to be beneficial in the management of
hyperlipidemia and the reduction of cardiovascular morbidity and mortality, rates of major …

Background—Previous studies using quantitative coronary angiography have demonstrated
that statin therapy slows the progression of coronary stenoses in proportion to average low …

Background: In patients with myocardial infarction, β-adrenergic blockers reduce recurrent
myocardial infarction and total mortality rates. However, whether a direct influence of β …

Background: A previous study reported that amlodipine retarded coronary plaque
progression in patients with coronary artery disease. The goal of this multicenter study was …

Coronary heart disease remains a leading cause of morbidity and mortality. Surrogate
imaging endpoints may allow smaller sample sizes and shorter study durations to expedite …

Atherosclerosis imaging has taken on increasing importance in the understanding of the
natural history of coronary artery disease and the processes leading to luminal narrowing …